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Résumé en
anglais
Due to its pivotal role in NADH oxidation and ATP synthesis, mitochondrial complex I
(CI) emerged as a crucial regulator of cellular metabolism. A functional CI relies on the
sequential assembly of nuclear- and mtDNA-encoded subunits; however, whether CI
assembly status is involved in the metabolic adaptations in CI deficiency still remains
largely unknown. Here, we investigated the relationship between CI functions, its
structure and the cellular metabolism in 29 patient fibroblasts representative of most
CI mitochondrial diseases. Our results show that, contrary to the generally accepted
view, a complex I deficiency does not necessarily lead to a glycolytic switch, i.e. the so-
called Warburg effect, but that this particular metabolic adaptation is a feature of CI
assembly defect. By contrast, a CI functional defect without disassembly induces a
higher catabolism to sustain the oxidative metabolism. Mechanistically, we
demonstrate that reactive oxygen species overproduction by CI assembly
intermediates and subsequent AMPK-dependent Pyruvate Dehydrogenase inactivation
are key players of this metabolic reprogramming. Thus, this study provides a two-way-
model of metabolic responses to CI deficiencies that are central not only in defining
therapeutic strategies for mitochondrial diseases, but also in all pathophysiological
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